Novel lipid nanoparticle adjuvants vaccine for porcine reproductive and respiratory syndrome (PRRS) using in-vitro macrophage assays
RNA-seq (gene expression) · mouse · 36 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Mus musculus (mouse)
- Samples
- 36 samples: 12 conditions, mostly in triplicateGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE246438_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1032933 and SRA study SRP468859. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 36 samples.
How we read this: 12 replicated groups read from 36 sample titles; they account for 36 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM7868804 Control, replicate 1 Control,
- GSM7868805 Control, replicate 2 Control,
- GSM7868806 Control, replicate 3 Control,
- GSM7868807 DDAB/DOPE (55:45), replicate 1 45),
- GSM7868808 DDAB/DOPE (55:45), replicate 2 45),
- GSM7868809 DDAB/DOPE (55:45), replicate 3 45),
- GSM7868810 DDAB/DOPE (55:45) + PRRSV, replicate 1 45) + PRRSV,
- GSM7868811 DDAB/DOPE (55:45) + PRRSV, replicate 2 45) + PRRSV,
- GSM7868812 DDAB/DOPE (55:45) + PRRSV, replicate 3 45) + PRRSV,
- GSM7868813 DDAB/DOPE (55:45) + TriAdj (2:1), replicate 1 45) + TriAdj (2:1),
- GSM7868814 DDAB/DOPE (55:45) + TriAdj (2:1), replicate 2 45) + TriAdj (2:1),
- GSM7868815 DDAB/DOPE (55:45) + TriAdj (2:1), replicate 3 45) + TriAdj (2:1),
- GSM7868816 DDAB/DOPE (55:45) + TriAdj (3:2), replicate 1 45) + TriAdj (3:2),
- GSM7868817 DDAB/DOPE (55:45) + TriAdj (3:2), replicate 2 45) + TriAdj (3:2),
- GSM7868818 DDAB/DOPE (55:45) + TriAdj (3:2), replicate 3 45) + TriAdj (3:2),
- GSM7868819 DDAB/DOPE (55:45) + TriAdj (2:1) + PRRSV, replicate 1 45) + TriAdj (2:1) + PR…
- GSM7868820 DDAB/DOPE (55:45) + TriAdj (2:1) + PRRSV, replicate 2 45) + TriAdj (2:1) + PR…
- GSM7868821 DDAB/DOPE (55:45) + TriAdj (2:1) + PRRSV, replicate 3 45) + TriAdj (2:1) + PR…
- GSM7868822 DDAB/DOPE/DSPC/CHOL (40:30:20:10), replicate 1 30:20:10),
- GSM7868823 DDAB/DOPE/DSPC/CHOL (40:30:20:10), replicate 2 30:20:10),
- GSM7868824 DDAB/DOPE/DSPC/CHOL (40:30:20:10), replicate 3 30:20:10),
- GSM7868825 DDAB/DOPE/DSPC/CHOL (40:30:20:10) + PRRSV, replicate 1 30:20:10) + PRRSV,
- GSM7868826 DDAB/DOPE/DSPC/CHOL (40:30:20:10) + PRRSV, replicate 2 30:20:10) + PRRSV,
- GSM7868827 DDAB/DOPE/DSPC/CHOL (40:30:20:10) + PRRSV, replicate 3 30:20:10) + PRRSV,
- GSM7868828 DDAB/DOPE/DSPC/CHOL (40:30:20:10) + TriAdj (2:1), replicate 1 30:20:10) + TriAdj (2:1…
- GSM7868829 DDAB/DOPE/DSPC/CHOL (40:30:20:10) + TriAdj (2:1), replicate 2 30:20:10) + TriAdj (2:1…
- GSM7868830 DDAB/DOPE/DSPC/CHOL (40:30:20:10) + TriAdj (2:1), replicate 3 30:20:10) + TriAdj (2:1…
- GSM7868831 DDAB/DOPE/DSPC/CHOL (40:30:20:10) + TriAdj (3:2), replicate 1 30:20:10) + TriAdj (3:2…
- GSM7868832 DDAB/DOPE/DSPC/CHOL (40:30:20:10) + TriAdj (3:2), replicate 2 30:20:10) + TriAdj (3:2…
- GSM7868833 DDAB/DOPE/DSPC/CHOL (40:30:20:10) + TriAdj (3:2), replicate 3 30:20:10) + TriAdj (3:2…
- GSM7868834 DDAB/DOPE/DSPC/CHOL (40:30:20:10) + TriAdj (2:1) + PRRSV, replicate 1 30:20:10) + TriAdj (2:1…
- GSM7868835 DDAB/DOPE/DSPC/CHOL (40:30:20:10) + TriAdj (2:1) + PRRSV, replicate 2 30:20:10) + TriAdj (2:1…
- GSM7868836 DDAB/DOPE/DSPC/CHOL (40:30:20:10) + TriAdj (2:1) + PRRSV, replicate 3 30:20:10) + TriAdj (2:1…
- GSM7868837 TriAdj, replicate 1 TriAdj,
- GSM7868838 TriAdj, replicate 2 TriAdj,
- GSM7868839 TriAdj, replicate 3 TriAdj,
- GSE279372 Lipid nanoparticles as adjuvant of Norovirus VLP vaccine augment cellular and humoral immune responses in a TLR 9- and type I IFN-dependent pathway 28 samples shares nanoparticle, vaccine
- GSE239649 Micronanoparticled risedronate exhibits potent vaccine adjuvant effects 21 samples shares nanoparticle, vaccine
- GSE272499 Recombinant RSV G protein vaccine induces enhanced respiratory disease via IL-13 and mucin overproduction 16 samples shares respiratory, vaccine
- GSE312613 Cell signaling pathways modulation in silica nanoparticle-saturated macrophages 15 samples shares nanoparticle, macrophage
- GSE239643 Micronanoparticled risedronate exhibits potent vaccine adjuvant effects [RNA-Seq] 12 samples shares nanoparticle, vaccine
- GSE298731 Th1 effector cells and macrophages facilitate respiratory IgA after mucosal vaccination 12 samples shares respiratory, macrophage
- GSE279743 Low-inflammatory lipid nanoparticle-based mRNA vaccine elicits protective immunity against H5N1 high-pathogenicity avian influenza virus with reduced adverse reactions (using whole lymph node) 9 samples shares nanoparticle, vaccine
- GSE239646 Micronanoparticled risedronate exhibits potent vaccine adjuvant effects [scRNA-Seq] 9 samples shares nanoparticle, vaccine
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.